Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.

Announcements

5,263

Total raised

£158B

disclosed amounts

Seed
£3.3M

The seed round was led by Nexus Venture Partners with participation from athlete investment collective 4CAST.

"The medical tourism market holds immense untapped value, and The Medical Travel Company’s full-stack model is the key to unlocking it. Having founded one of India’s most successful consumer-tech stories, Sahil, Ankit and their team are uniquely positioned to build trust and capture this opportunity. India has long been a leading medical frontier, with world-class practitioners and cutting-edge technology; it’s about time this excellence is made globally accessible"
— Pratik Poddar, Partner
Pre-Seed
£1.9M

Connect Ventures led the pre-seed round as the company emerged from stealth.

"While the TMS is the system of record for our customers, many of the conversations, decisions and data that drive freight never make it inside. That missing information is where revenue is lost and service breaks down. Bridging that gap is the only way to unlock real automation and enable the revenue growth and operational resilience forwarders need in today's market. Rates and contracts underpin freight forwarding, and are especially pertinent in the current environment. Starting here enables the biggest commercial impact for our customers while building the core grounding for future automation for our customers."
— Dan Bailey, CEO and co-founder
Series A
€80.0M

The financing round was led by IQ Capital to accelerate clinical trials for glioblastoma and other solid tumours.

"This significant investment accelerates our lead programme in glioblastoma and follow-on programme in colorectal cancer liver metastases through the clinic, advances our pipeline in liver and lung cancers, and further enhances our Odysseus platform. We are honoured to have the support of existing and new investors who share our mission to deliver breakthrough treatments and pursue cures for the thousands of patients and families facing devastating diagnoses each year."
— Ken Macnamara, Chief Executive Officer
£2.0M

The funding round was backed by existing investors Mercia and Crown Fund to support international growth.

"The mid-market is in a gap-zone of cybersecurity: too complex for basic tools, too niche for enterprise-level bespoke providers. Talion’s Hybrid Defence model fills that gap by offering transparency, shared control, and solutions scaled to the needs of firms that are growing fast but can’t afford to be overcharged or left exposed. With this investment, we can accelerate our innovation in MDR, threat intelligence, and service delivery for mid-sized enterprises."
— Keven Knight, CEO